Cascade search for HSV-1 combinatorial drugs with high antiviral efficacy and low toxicity
Author(s) -
Ho,
Sánchez,
Shahangian,
Al-Shyoukh,
Cheng
Publication year - 2012
Publication title -
international journal of nanomedicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.245
H-Index - 128
eISSN - 1178-2013
pISSN - 1176-9114
DOI - 10.2147/ijn.s27540
Subject(s) - drug , ribavirin , antiviral drug , herpes simplex virus , pharmacology , toxicity , drug discovery , virus , medicine , biology , virology , bioinformatics , hepatitis c virus
Infectious diseases cause many molecular assemblies and pathways within cellular signaling networks to function aberrantly. The most effective way to treat complex, diseased cellular networks is to apply multiple drugs that attack the problem from many fronts. However, determining the optimal combination of several drugs at specific dosages to reach an endpoint objective is a daunting task.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom